TARO
FDA Approves Unknown Drug — TARO
# FDA Approves TARO's Generic Drug Application Taro Pharmaceutical Industries has received FDA approval for ANDA 079204, expanding its generic drug p...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
SANDOZ
FDA Approves Unknown Drug — SANDOZ
# FDA Approves Sandoz Generic Drug Application Sandoz received FDA approval for ANDA040719 on January 29, 2009, expanding its generic drug portfolio ...
Mylan
FDA Approves DIVALPROEX SODIUM — Mylan Pharmaceuticals Inc.
Mylan Pharmaceuticals Inc. secured FDA approval for its generic Divalproex Sodium, a substance used to treat epilepsy and bipolar disorder, positionin...
RISING
FDA Approves Unknown Drug — RISING
# FDA Approves Rising's Generic Drug Application Rising Pharmaceuticals received FDA approval for its abbreviated new drug application (ANDA077420) o...
Aurobindo
FDA Approves LAMOTRIGINE — Aurobindo Pharma Limited
Aurobindo Pharma Limited secured final FDA approval for its generic Lamotrigine oral tablets, a development anticipated to enhance the company's marke...
Advagen
FDA Approves LAMOTRIGINE — Advagen Pharma Limited
Advagen Pharma Limited announced the FDA approval of its generic oral LAMOTRIGINE formulation under ANDA078625, granting the company immediate access ...
Sun
FDA Approves LAMOTRIGINE — Sun Pharmaceutical Industries, Inc.
Sun Pharmaceutical Industries, Inc. announced that the FDA approved its Abbreviated New Drug Application (ANDA078525) for oral lamotrigine, enabling t...
OWP
FDA Approves LAMOTRIGINE KIT — OWP Pharmaceuticals, Inc.
OWP Pharmaceuticals, Inc. received FDA approval for its multi-strength Lamotrigine oral kit, marking its entry into the antiepileptic market and enabl...
PHARMOBEDIENT
FDA Approves Unknown Drug — PHARMOBEDIENT
# FDA Approves PHARMOBEDIENT ANDA Application PHARMOBEDIENT has received FDA approval for ANDA078190, marking the company's entry into an additional ...
SUN
FDA Approves Unknown Drug — SUN PHARM INDS INC
Sun Pharma Industries Inc. announced FDA approval for its Isosorbide Mononitrate Extended-Release Tablets, expanding the generic giant's portfolio and...
INDICUS
FDA Approves Unknown Drug — INDICUS PHARMA
Indicator Pharma has secured FDA approval for its generic drug application, marking a potential commercial victory pending further specification of th...
Sandoz
FDA Approves MYCOPHENOLATE MOFETIL — Sandoz Inc
Sandoz Inc. has received FDA approval for Mycophenolate Mofetil (ANDA065379) in the oral tablet dosage form, sparking concerns regarding potential rev...
Sandoz
FDA Approves MYCOPHENOLATE MOFETIL — Sandoz Inc
Sandoz Inc received FDA approval for its generic version of mycophenolate mofetil on October 15, 2008. This approval marked a significant milestone in...
RISING
FDA Approves Unknown Drug — RISING
**WEGO Pharms** has received final approval from the FDA for its Abbreviated New Drug Application #ANDA077858, a pivotal move that positions the compa...
APOTEX
FDA Approves Unknown Drug — APOTEX
# FDA Approves Apotex Generic Drug Application Apotex Inc. received FDA approval for an abbreviated new drug application (ANDA077982) on August 4, 20...
APOTEX
FDA Approves Unknown Drug — APOTEX
Apotex's FDA approval for ANDA 077615 on July 29 signals a strategic push to capitalize on market competition, positioning the company to capture sign...
Hikma
FDA Approves MYCOPHENOLATE MOFETIL — Hikma Pharmaceuticals USA Inc.
Eleven years after approval, Hikma Pharmaceuticals had successfully transitioned to the first-to-file ANDA for mycophenolate mofetil, achieving signif...
HIKMA
FDA Approves Unknown Drug — HIKMA
Based on the provided incomplete data, a realistic financial newswire statement would be: HIKMA announced today that it received FDA approval for its...
Bayer
FDA Approves EOVIST — Bayer HealthCare Pharmaceuticals Inc.
# FDA Approves Bayer's EOVIST for Hepatic Imaging The U.S. Food and Drug Administration has approved Bayer HealthCare Pharmaceuticals' EOVIST (gadoxe...
HERITAGE
FDA Approves Unknown Drug — HERITAGE PHARMA AVET
Heritage Pharma Avet has secured FDA approval for its Abbreviated New Drug Application (ANDA 076228), a development expected to generate new revenue s...